These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9201249)
21. Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia. Sharabani H; Izumchenko E; Wang Q; Kreinin R; Steiner M; Barvish Z; Kafka M; Sharoni Y; Levy J; Uskokovic M; Studzinski GP; Danilenko M Int J Cancer; 2006 Jun; 118(12):3012-21. PubMed ID: 16395705 [TBL] [Abstract][Full Text] [Related]
22. Evidence for a labile intermediate in the butyrate induced reduction of the level of c-myc RNA in SW837 rectal carcinoma cells. Herold KM; Rothberg PG Oncogene; 1988 Oct; 3(4):423-8. PubMed ID: 3078950 [TBL] [Abstract][Full Text] [Related]
23. Doxorubicin-induced alterations of c-myc and c-jun gene expression in rat glioblastoma cells: role of c-jun in drug resistance and cell death. Pourquier P; Montaudon D; Huet S; Larrue A; Clary A; Robert J Biochem Pharmacol; 1998 Jun; 55(12):1963-71. PubMed ID: 9714316 [TBL] [Abstract][Full Text] [Related]
24. Differentiating effect of sodium butyrate on human hepatoma cell lines PLC/PRF/5, HCC-M and HCC-T. Saito H; Morizane T; Watanabe T; Kagawa T; Miyaguchi S; Kumagai N; Tsuchiya M Int J Cancer; 1991 May; 48(2):291-6. PubMed ID: 1708367 [TBL] [Abstract][Full Text] [Related]
25. Novel mutual prodrug of retinoic and butyric acids with enhanced anticancer activity. Nudelman A; Rephaeli A J Med Chem; 2000 Jul; 43(15):2962-6. PubMed ID: 10956204 [TBL] [Abstract][Full Text] [Related]
26. Suppression of metastatic potential of high-metastatic Lewis lung carcinoma cells by vanadate, an inhibitor of tyrosine phosphatase, through inhibiting cell-substrate adhesion. Takenaga K Invasion Metastasis; 1996; 16(2):97-106. PubMed ID: 9030244 [TBL] [Abstract][Full Text] [Related]
27. Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis. Zimra Y; Nudelman A; Zhuk R; Rabizadeh E; Shaklai M; Aviram A; Rephaeli A J Cancer Res Clin Oncol; 2000 Dec; 126(12):693-8. PubMed ID: 11153141 [TBL] [Abstract][Full Text] [Related]
28. Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice. Giermasz A; Makowski M; Kozłowska E; Nowis D; Maj M; Jalili A; Feleszko W; Wójcik C; Dabrowska A; Jakóbisiak M; Gołab J Int J Cancer; 2002 Feb; 97(6):746-50. PubMed ID: 11857349 [TBL] [Abstract][Full Text] [Related]
29. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells. Tsai LC; Hung MW; Chang GG; Chang TC Anticancer Res; 2000; 20(4):2441-8. PubMed ID: 10953308 [TBL] [Abstract][Full Text] [Related]
30. Sodium butyrate inhibits c-myc splicing and interferes with signal transduction in ovarian carcinoma cells. Krupitza G; Harant H; Dittrich E; Szekeres T; Huber H; Dittrich C Carcinogenesis; 1995 May; 16(5):1199-205. PubMed ID: 7767986 [TBL] [Abstract][Full Text] [Related]
31. The induction of vimentin gene expression by sodium butyrate in human promonocytic leukemia U937 cells. Rius C; Cabañas C; Aller P Exp Cell Res; 1990 May; 188(1):129-34. PubMed ID: 2328771 [TBL] [Abstract][Full Text] [Related]
32. Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells. Joshi SS; Sinangil F; Sharp JG; Mathews NB; Volsky DJ; Brunson KW Cancer Detect Prev; 1988; 11(3-6):405-17. PubMed ID: 3390859 [TBL] [Abstract][Full Text] [Related]
33. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M. Liu J; Clegg CH; Shoyab M Cell Growth Differ; 1992 May; 3(5):307-13. PubMed ID: 1633113 [TBL] [Abstract][Full Text] [Related]
34. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Kakar SS; Roy D Cancer Lett; 1994 Nov; 87(1):85-9. PubMed ID: 7954373 [TBL] [Abstract][Full Text] [Related]
35. c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression. Yamit-Hezi A; Plaksin D; Eisenbach L Oncogene; 1994 Apr; 9(4):1065-79. PubMed ID: 8134110 [TBL] [Abstract][Full Text] [Related]
36. Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun, and c-myc proto-oncogenes: role of cellular calcium and reactive oxygen species. Joseph P; Muchnok TK; Klishis ML; Roberts JR; Antonini JM; Whong WZ; Ong T Toxicol Sci; 2001 Jun; 61(2):295-303. PubMed ID: 11353138 [TBL] [Abstract][Full Text] [Related]
37. Genes related to growth and invasiveness are repressed by sodium butyrate in ovarian carcinoma cells. Krupitza G; Grill S; Harant H; Hulla W; Szekeres T; Huber H; Dittrich C Br J Cancer; 1996 Feb; 73(4):433-8. PubMed ID: 8595156 [TBL] [Abstract][Full Text] [Related]
38. Silencing stem cell factor attenuates stemness and inhibits migration of cancer stem cells derived from Lewis lung carcinoma cells. Wang L; Wang J; Li Z; Liu Y; Jiang M; Li Y; Cao D; Zhao M; Wang F; Luo F Tumour Biol; 2016 Jun; 37(6):7213-27. PubMed ID: 26666817 [TBL] [Abstract][Full Text] [Related]
39. Characterization and tumorigenicity of a butyrate-adapted T24 bladder cancer cell line. Flatow U; Rabson AB; Hand PH; Willingham MC; Rabson AS Cancer Invest; 1989; 7(5):423-35. PubMed ID: 2695227 [TBL] [Abstract][Full Text] [Related]
40. [The effects of a novel aminosteroid on WEHI-3B leukemia cells]. He Q; Na XD; Jiang DZ Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):435-9. PubMed ID: 12212110 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]